SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-23-000100
Filing Date
2023-11-14
Accepted
2023-11-13 17:45:23
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20230930.htm   iXBRL 10-Q 1126730
2 EX-10.5 exhibit105formoflockupagre.htm EX-10.5 36367
3 EX-31.1 skye-20230930xex311.htm EX-31.1 10498
4 EX-31.2 skye-20230930xex312.htm EX-31.2 11027
5 EX-32.1 skye-20230930xex321.htm EX-32.1 5079
6 EX-32.2 skye-20230930xex322.htm EX-32.2 5219
  Complete submission text file 0001516551-23-000100.txt   7034768

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20230930.xsd EX-101.SCH 67790
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20230930_cal.xml EX-101.CAL 73662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20230930_def.xml EX-101.DEF 344764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20230930_lab.xml EX-101.LAB 720632
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20230930_pre.xml EX-101.PRE 487228
69 EXTRACTED XBRL INSTANCE DOCUMENT skye-20230930_htm.xml XML 835222
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 231400376
SIC: 2834 Pharmaceutical Preparations